• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC PENTARAY NAV HIGH-DENSITY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC PENTARAY NAV HIGH-DENSITY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY Back to Search Results
Catalog Number UNK_PENTARAY
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Tamponade (2226); No Code Available (3191)
Event Date 01/23/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.(b)(4).
 
Event Description
It was reported that a patient underwent left idiopathic ventricular tachycardia - left (l-idvt) ablation with pentaray nav high-density mapping catheter and suffered cardiac tamponade requiring pericardiocentesis and surgical intervention.The event occurred during use of biosense webster, inc.Product.During an idiopathic left sided premature ventricular contraction (pvc) procedure, it was observed by ultrasound that the patient developed a pericardial effusion.A pericardiocentesis was performed in which 1600 cc's were removed from the pericardial space.The patient was transferred to the operating room for surgical repair.There was no information about the hospitalization.The physician stated that the splines of the pentaray nav high-density mapping catheter caused 2 holes in the heart.Multiple attempts have been made to obtain clarification to this complaint.However, no further information has been made available.Since the physician provided a specific injury mechanism after surgical intervention, the event will be reported only under the pentaray nav high-density mapping catheter.
 
Manufacturer Narrative
Additional information was received on february 13, 2020 that the device was discarded.Therefore, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Manufacturer Narrative
Initially, the physician stated that the splines of the pentaray nav high-density mapping catheter caused 2 holes in the heart.Since the physician provided a specific injury mechanism after surgical intervention, the event was reported under the pentaray nav high-density mapping catheter (g9: manufacturer report number.Additional information was received on april 7, 2020, stating the surgeon saw two openings and initially suggested that they were caused by the pentaray nav high-density mapping catheter.The electrophysiologist and the sales representative herself disagreed and two more experienced surgeons were consulted.They confirmed that based on the size and location of the perforations, one was caused by the ablation catheter ¿thermocool® smart touch® sf bi-directional navigation catheter¿ and the other by the unknown brand needle during the pericardiocentesis.The patient fully recovered and was discharged.Therefore, the event was reassessed as reportable under the thermocool® smart touch® sf bi-directional navigation catheter (g9: manufacturer report number: 2029046-2020-00571) and the pentaray nav high-density mapping catheter reportability was reassessed to not reportable as a concomitant product.The ¿d11: concomitant medical products and therapy dates¿ section was processed to reflect the ¿pentaray nav high-density mapping catheter¿ and the ¿unknown brand needle¿.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.No: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENTARAY NAV HIGH-DENSITY MAPPING CATHETER
Type of Device
CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
MDR Report Key9714573
MDR Text Key191683470
Report Number2029046-2020-00248
Device Sequence Number1
Product Code MTD
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 01/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_PENTARAY
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/23/2020
Initial Date FDA Received02/14/2020
Supplement Dates Manufacturer Received02/13/2020
04/07/2020
Supplement Dates FDA Received02/26/2020
04/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
THMCL SMTCH SF BID, TC, D-F; UNKNOWN BRAND NEEDLE; UNK_PENTARAY
Patient Outcome(s) Life Threatening; Required Intervention;
-
-